The in vitro diagnostic group BIOMERIEUX-PIERRE FABRE and the Atomic Energy Commission (CEA) have announced the creation of a joint subsidiary specialised in biochips. Named APIBIO, it will be responsible for developing, manufactures and markets miniaturised biological and biochemical tests.